IS EXTERNAL REFERENCE PRICING A THREAT TO INTERNATIONAL EQUAL AFFORDABILITY?

被引：0
|
作者：
Ansaripour, A. [1 ]
Franken, M. [1 ]
Uyl-de Groot, C. [2 ]
Kalo, Z. [3 ]
Redekop, W. K. [4 ]
机构：
[1] Erasmus Univ, Rotterdam, Netherlands
[2] Natl Hlth Care Inst, Diemen, Netherlands
[3] Eotvos Lorand Univ, Budapest, Hungary
[4] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.2359
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN283
引用
收藏
页码：A759 / A760
页数：2
相关论文
共 50 条
  • [31] INTERNATIONAL REFERENCE PRICING ANALYSIS OF MEDICINES IN TURKIYE BY 2022
    Citil, E.
    Okcun, S.
    Kockaya, G.
    VALUE IN HEALTH, 2023, 26 (12) : S293 - S293
  • [32] INTERNATIONAL REFERENCE PRICING ANALYSIS OF MEDICINES IN TURKIYE BY 2021
    Karahan, E. B.
    Kockaya, G.
    Erkut, Y.
    VALUE IN HEALTH, 2022, 25 (12) : S246 - S246
  • [33] PROPOSED US INTERNATIONAL REFERENCE PRICING, POSSIBLE IMPACT
    Mycka, J.
    Lobb, W.
    Dellamano, R.
    Dalal, N.
    Pereira, E.
    Dellamano, L.
    VALUE IN HEALTH, 2020, 23 : S300 - S300
  • [34] International Reference Pricing in the Context of US Drug Policy
    Frank, Richard
    Conti, Rena M.
    Gruber, Jonathan
    JOURNAL OF HEALTH POLITICS POLICY AND LAW, 2022, 47 (06) : 779 - 796
  • [35] HOW AFFORDABILITY IS CONSIDERED FOR PRICING POLICIES?
    Remuzat, C.
    Francois, C.
    Toumi, M.
    VALUE IN HEALTH, 2018, 21 : S202 - S202
  • [36] INTERNATIONAL REFERENCE PRICING AND JOINT CLINICAL ASSESSMENTS-HOW WILL EUROPEAN-LEVEL HTA EVALUATIONS IMPACT INTERNATIONAL REFERENCE PRICING AND LAUNCH SEQUENCING?
    Saei, A.
    Tutulea, E.
    Perez-Kempner, L.
    VALUE IN HEALTH, 2023, 26 (12) : S2 - S2
  • [37] Variations in external reference pricing implementation: does it matter for public policy?
    Jennifer Gill
    Anna-Maria Fontrier
    Dionysis Kyriopoulos
    Panos Kanavos
    The European Journal of Health Economics, 2019, 20 : 1375 - 1397
  • [38] EXTERNAL REFERENCE PRICING IMPACT OF THE INTEGRATION OF THE AMNOG DISCOUNT IN THE LIST PRICE
    Thivolet, M.
    Cetinsoy, L.
    Vataire, A. L.
    Remuzat, C.
    Brunet, J.
    Kornfeld, A.
    Toumi, M.
    VALUE IN HEALTH, 2014, 17 (07) : A423 - A423
  • [39] Variations in external reference pricing implementation: does it matter for public policy?
    Gill, Jennifer
    Fontrier, Anna-Maria
    Kyriopoulos, Dionysis
    Kanavos, Panos
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2019, 20 (09): : 1375 - 1397
  • [40] Bifurcation analysis of dynamic pricing processes with nonlinear external reference effects
    Lu, Shuixiu
    Oberst, Sebastian
    Zhang, Guoqiang
    Luo, Zongwei
    COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION, 2019, 79
12345